Intervention not reported
Preterm birth < 37 weeks · singleton pregnancy with symptoms of PTL
It is very uncertain whether the intervention changes preterm birth < 37 weeks (very low certainty).
1 finding from 1 review
Health‐related quality of life · cancer patients
1 finding from 1 review
Distress at · cancer patients
1 finding from 1 review
Care needs · cancer patients
1 finding from 1 review
Caregiver depression ( · caregiver‐infant dyads
Summary of findings: NBAS or NBO showed no clear difference in caregiver mental health (depression), dichotomous data Assessed at… compared with control (low certainty).
1 finding from 1 review
Infant social, emotional, cognitive and motor development Assessed when infant aged 4 months, using the BSID; higher scores indicate better development · caregiver‐infant dyads
1 finding from 1 review
Caregiver perception of infant (parents' perception of the degree of difficult temperament of the infant) Assessed at postintervention, 8 weeks after delivery; higher score indicates better outcome · caregiver‐infant dyads
1 finding from 1 review
Caregiver stress (maternal perceptions of her adjustment to the parenting role) Assessed when infant aged 4 months, using the PSI · caregiver‐infant dyads
1 finding from 1 review
Caregiver knowledge (related to infants' physical capacities, including reflexes and senses) Assessed at postintervention, using multiple choice factual questions; higher scores indicate better outcome · caregiver‐infant dyads
1 finding from 1 review
Intervention not reported
Comparative studies · children and adolescents aged 18 years and under diagnosed with ADHD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Serious adverse events Measured by: proportion of serious adverse events (total) Average study duration (range): not stated · children and adolescents aged 18 years and under diagnosed with ADHD
It is very uncertain whether the intervention changes serious adverse events Measured by: proportion of serious adverse… (very low certainty).
1 finding from 1 review
Intervention not reported
Non‐comparative studies · children and adolescents aged 18 years and under diagnosed with ADHD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Serious adverse events Measured by: proportion of any serious adverse events Average study duration (range): 4.7 months (14 days to 21 months) · children and adolescents aged 18 years and under diagnosed with ADHD
1 finding from 1 review
Intervention not reported
Withdrawal of methylphenidate due to serious adverse events (non‐comparative cohort studies) Measured by: proportion of participants withdrawn from treatment Average study duration (range): 7.9 months (1 month to 37 months) · children and adolescents aged 18 years and under diagnosed with ADHD
1 finding from 1 review
Intervention not reported
Withdrawal of methylphenidate due to adverse events of unknown severity Measured by: proportion of participants withdrawn from treatment Average study duration (range): 4.6 months (21 days to 36 months) · children and adolescents aged 18 years and under diagnosed with ADHD
1 finding from 1 review
Intervention not reported
Non‐serious adverse events Measured by: proportion of any non‐serious adverse events Average study duration (range): 5.99 months (1 day to 41 months) · children and adolescents aged 18 years and under diagnosed with ADHD
1 finding from 1 review
Intervention not reported
Withdrawal of methylphenidate due to non‐serious adverse events Measured by: proportion of participants withdrawn from treatment Average study duration (range): 5.60 months (0.6 months to 41 months) · children and adolescents aged 18 years and under diagnosed with ADHD
1 finding from 1 review
Intervention not reported
Withdrawal of methylphenidate for unknown reasons Measure by: proportion of participants withdrawn from treatment Average study duration (range): 6.13 months (1 day to 36 months) · children and adolescents aged 18 years and under diagnosed with ADHD
1 finding from 1 review
Intervention not reported
Mortality · Improving outcomes in older adult people admitted to a surgical service.
The intervention showed no clear difference in mortality (moderate certainty).
1 finding from 1 review
RR 0.85 [0.68, 1.05]
1316 participants
Moderate
Intervention not reported
Discharge to an increased level of care · Improving outcomes in older adult people admitted to a surgical service.
The intervention leads to lower discharge to an increased level of care (high certainty).
1 finding from 1 review
RR 0.71 [0.55, 0.92]
941 participants
High